For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Legal Brief
Petition for Review of an Order of the National Highway Traffic Safety Administration
Legal Brief
CEI’s CAFE Litigation
Full Document Avalible in PDF In the 1980s, CAFE was the subject of several lawsuits by the Center for Auto Safety and…
Legal Brief
Oral Argument in CEI and CA vs. Paul O Neill and Bradley Buckles
Study
Hidden Truth: The Perils and Protection of Off-Label Drug and Medical Device Promotion
Full Document Available in PDF What can you do if you learn you have a life-threatening…
Blog
The Limits of Government-Funded Psychology: 9/11 Counseling Backfires
After school shootings, psychologists fan out and provide “grief counseling” to student bodies, but it’s far from clear that this does any good. Critics say…
News Max